The Cancer Hospital of New Jersey
Located across the street from Robert Wood Johnson University Hospital, the Cancer Institute of New Jersey (CINJ) serves as the nucleus of the most innovative cancer treatment and research centers in the state. At CINJ, laboratory research is supported by more than $80 million annually in cancer-related research grants.
Research is being conducted in areas including oncogenes, epidemiology, chemical carcinogenesis, tumor virology and immunology, drug development and resistance, the relationship between cellular and genetic mechanisms and tumor development, and cancer genomics. Patients have unprecedented access to clinical trials that may provide the latest treatment options.
Clinical trials are studies, managed by government agencies, educational institutions, private not-for-profit organizations, or commercial businesses, to develop, produce, and evaluate the effectiveness of new treatments and therapies for diseases.
New Jersey Cancer Trial Connect, a web-based resource for healthcare providers and cancer patients, was launched in 2003 to enable people to identify active clinical trials that may be appropriate treatment options. Operated by CINJ with support from the state of New Jersey, the service contains trial information provided by hospitals, academic institutions, oncology offices, and pharmaceutical companies. New Jersey Cancer Trial Connect enables people with cancer, their families and caregivers to enter specific information about their cancer diagnosis and treatment history. The system will then search its database to find a clinical trial "match." Patients are notified electronically when new clinical trials become available.